Cardica Announces Publication of Pivotal PAS-Port(R) Proximal Anastomosis System Clinical Trial Results
REDWOOD CITY, Calif., July 22 /PRNewswire-FirstCall/ -- Cardica, Inc. (Nasdaq: CRDC ) today announced that the full results of the PAS-Port system
multi-center pivotal trial, known as the EPIC trial, were published in the July issue of the peer-reviewed publication The J ournal ...
Elbit Imaging Ltd. Announces - Swiss Team Uses InSightec's ExAblate(R) 4000 Brain System to Treat Patients With Functional Brain Disorders
TEL AVIV, Israel, July 14 /PRNewswire-FirstCall/ -- Elbit Imaging Ltd.
(TASE: EMIT, Nasdaq: EMITF ), announced today that, its subsidiary (in which
EI holds indirectly approximately 58.34%, InSightec Ltd., announced today
that a team at the University Children's Hospital Zurich has completed...
Iontophoretic Drug Delivery System (IDDS) Containing Lidocaine and Epinephrine is Effective in Reducing Pain Associated With Insertion of an Intravenous Catheter in a Phase 2 Clinical Trial
SEATTLE, July 9 /PRNewswire/ -- Dharma Therapeutics, Inc., ("Dharma") Seattle, WA (a subsidiary of the Transcu Group Limited, a company listed on the Singapore Exchange Limited) announced that its improved active transdermal delivery technology, which administers lidocaine and epinephrine through ...
Published Study Shows VNUS ClosureFAST(TM) System Significantly Superior to Laser for Varicose Vein Treatment
Journal of Vascular & Interventional Radiology Cites Improved Recovery and Quality-of-Life with VNUS Technology
SAN JOSE, Calif., June 10 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS ), a worldwide leader in medical devices for the minimally invasive tr...
Cardiogenesis Announces Presentation of its PHOENIX(R) Combination TMR Plus Stem Cell Delivery System at the International Society of Minimally Invasive Cardiothoracic Surgeons (ISMICS) Annual Meeting
IRVINE, Calif., June 4 /PRNewswire-FirstCall/ -- Cardiogenesis Corporation (Pink Sheets: CGCP) the market leader in laser transmyocardial revascularization (TMR) for the treatment of chronic cardiac ischemia, announces that Dr. Naresh Trehan of New Delhi will be presenting his clinical results of ...
Definitive Outcomes of Radiofrequency Ablation for Barrett's Esophagus Using the HALO Ablation System Reported at the Digestive Disease Week Meeting for Gastroenterologists and Esophageal Surgeons
Radiofrequency ablation is durable after 2 years, compares favorably with endoscopic resection for advanced disease, and reduces the risk for cancer progression
SUNNYVALE, Calif., June 3 /PRNewswire/ -- Results from a number of clinical trials were presented during the Digestive Disease Wee...
New Therapy Enlists Immune System to Boost Cure Rate in a Childhood Cancer
--In a First, Immunotherapy Works Against Neuroblastoma--
PHILADELPHIA, May 28 /PRNewswire-USNewswire/ -- A multicenter research team has announced encouraging results for an experimental therapy using elements of the body's immune system
to improve cure rates for children with neuroblastoma...
Siemens Corporate Research Develops RAPID2 System for Fast Discovery of Discriminative Pathogen Signatures
RAPID2 identifies relevant signatures for H1N1 virus in record time
PRINCETON, N.J., May 21 /PRNewswire-FirstCall/ -- Siemens Corporate Research (SCR), Inc. ( www.usa.siemens.com/research ) announced that it developed the RAPID2 system
to speed the biomarker discovery process for the devel...
SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(R) Stent System More Cost Effective Than Bypass Surgery in Patients With Complex Coronary Artery Disease
NATICK, Mass. and BARCELONA, Spain, May 20 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced results from an analysis of economic and quality of life outcomes, based on one-year data from its landmark SYNTAX trial. The results found that percutaneous coronary ...
Medizone International, Inc. (MZEI.PK): Trials of the AsepticSure Hospital Sterilization System Have Begun
SAN FRANCISCO, May 6 /PRNewswire-FirstCall/ -- Medizone (Pink Sheets: MZEI) is pleased to announce the commencement of the first in a series of trials designed to confirm that the Medizone AsepticSure(TM) Hospital Sterilization System
can rapidly eliminate hospital-based bacterial pathogens known ...
CareHere's Electronic Medication System Proves 100 Percent Effective in Response to Recall
NASHVILLE, Tenn., April 16 /PRNewswire/ -- When the U.S. Food and Drug Administration (FDA) issued a recall of a widely used heart medication last month, CareHere's proprietary medication tracking system
allowed the company to instantly generate a list of all patients taking the medication. For...
PEAK Surgical Announces Completion of First PRECISE Clinical Study, Receipt of Medical Design Excellence Award for PEAK(R) Surgery System and Achievement of Over 1,000 Surgeries Using PEAK PlasmaBlade(TM)
- Company Reports Significant Uptake of PlasmaBlade by U.S. Surgeons Since Product Launch -
PALO ALTO, Calif., April 7 /PRNewswire/ -- PEAK Surgical, Inc., a medical device company that has developed a new tissue dissection system
based on a proprietary technology, announced today several mil...
David Feldman, M.D. Appointed Co-Principal Investigator of DuraHeart(TM) Left Ventricular Assist System U.S. Clinical Trial
Joins Two Noted Cardiothoracic Surgeons to Lead Pivotal Trial
ANN ARBOR, Mich., March 17 /PRNewswire/ -- Terumo Heart Inc. today announced that it has appointed David Seth Feldman, MD/PhD, FACC, FAHA to be the Co-Principal Investigator for its Bridge-to-Transplant trial in the United States, ...
Lake Hospital System Receives $60,000 Grant for Groundbreaking Music Therapy Study
Participants Sought For Landmark Study To Measure Effects Of Music On Diabetes Outcomes
PAINESVILLE, Ohio, March 11 /PRNewswire/ -- Lake Hospital System
today announced that it has received a $60,000 grant from the Kulas Foundation to support a groundbreaking study that will measure th...
Neuralstem's Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS
Make Synaptic Contact with Host Motor Neurons
ROCKVILLE, Md., March 9 /PRNewswire-FirstCall/ -- Transplanted human neural stem cells (hNSCs) developed by Neuralstem, Inc. (NYSE Alternext US: CUR) made synaptic contacts with the motor neurons of rats with ALS-like symptoms, a paper published i...
Next Generation Proton Therapy System for Cancer Treatment Set for Release This Year
LITTLETON, Mass., Feb. 26 /PRNewswire/ -- Still River Systems announced today the successful operation of the world's highest field, high energy cyclotron magnet. Still River's magnet is the key technical element for reducing the size and cost of the particle accelerator that will deliver proton t...
Reproductive Partners Participates in New IVF Progesterone Delivery System Study
Southern California fertility center participates in a national study to explore new IVF progesterone delivery systems replacing intramuscular injections.
LOS ANGELES, Jan. 12 /PRNewswire/ -- Reproductive Partners Medical Group a leading Southern California fertility center esteemed for the...
ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers
Program Expands on Successful Results from prior U.S., U.K. and China Trials
SAN DIEGO, Jan. 7 /PRNewswire/ -- Vital Therapies, Inc. (VTI), a development stage company targeting liver disease, today announced patient enrollment has begun for a randomized, controlled, multi-center, Phase 2 cli...
Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells
Proves significance of AHCC for maintaining a healthy immune system
PURCHASE, N.Y., Jan. 6 /PRNewswire/ -- A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) ...
PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications
PALO ALTO, Calif., Dec. 17 /PRNewswire/ -- PEAK Surgical, Inc., a medical
device company that has developed a new tissue dissection system
based on a
proprietary technology, announced today that the U.S. Food and Drug
Administration (FDA) has granted the company 510(k) clearance to market its
USD 12.5 m Funding for the Development of Intercell's Vaccine Patch System for Pandemic Influenza From U.S. Department of Health and Human Services (HHS)
VIENNA, Austria, Dec. 11 /PRNewswire/ -- Intercell AG (VSE: ICLL) today
announced the execution of a contract modification with the U.S. Department of
Health and Human Services (HHS). The agreement commits additional funding of
USD 12.5 m for Intercell's Pandemic Influenza program.
MGuard(TM) Coronary Stent System Approved in Israel
TEL AVIV, Israel, December 8 /PRNewswire/ -- InspireMD, Ltd. announced
that the MGuard(TM) coronary stent system
has been approved for use in Israel
by the Israeli Ministry of Health.
The MGuard(TM) stent system
presents a novel combination of a coronary
stent merged with an embolic protec...
Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series
NEW YORK, Nov. 20 /PRNewswire/ -- Clinical data from a prospective
registry presented this week at the 35th Annual Veith Symposium shows DVT
treatment with the Trellis(R) Peripheral Infusion System
Vascular, Inc. (Santa Clara, CA) successfully breaks up the blood clot in most
Leading Healthcare System Decreases MRSA Infection Rate by 53 Percent - Offers Protocol & Educational Materials Free of Charge to Other Organizations
Infant Deaths Spur Hard-Hitting, System-Wide Hand Washing Campaign That Drives Culture Change, Saves Lives
CHARLOTTE, N.C., Sept. 16 /PRNewswire/ -- Novant Health, one of the top
10 integrated health systems in the country, dramatically increased
hand-washing compliance from ...
Symposium Highlights Yale Study Indicating Role of AHCC(R) for Immune System Enhancement and as a Promising Cancer Preventative
Significant Research Presented at the AHCC International Research Symposium
PURCHASE, N.Y., Sept. 16 /PRNewswire/ -- The 16th International AHCC(R)
(Active Hexose Correlated Compound) Symposium was held in Sapporo, Japan on
July 26th and 27th. The Symposium hosted by the AHCC Research Associatio...
Queen's University Chooses Xceed's Ziplex(R) System for Translational Research
Study to validate gene signature designed to predict outcomes in follicular lymphoma
WELLESLEY, Mass., Sept. 15 /PRNewswire/ -- Xceed Molecular, a pioneer
in the development of cost-effective, easy-to-use gene-expression analysis
systems, announced that Queen's Uni...
StemCor Systems Receives CE Mark for MarrowMiner(TM) System for Bone Marrow Collection
Receipt of CE Mark Clears the Way for Commercialization in the European Union
MENLO PARK, Calif., Sept. 10 /PRNewswire/ -- StemCor Systems, Inc., a
medical device company developing systems for Enabling Regenerative
Medicine(TM), announced today that the Company...
Catheter Ablation System for Atrial Fibrillation Shows Reduced Procedure Time, Remarkable Safety Profile and Excellent Outcomes in Two Clinical Studies
Important Studies Presented at the European Society of Cardiology Continue to Bring Attention to Innovative Technology
CARLSBAD, Calif., Sept. 2 /PRNewswire/ -- Ablation Frontiers, Inc.,
announced today that two important studies, involving its innovative atrial
Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008
Comprehensive Data Provide Initial Proof of Concept Across Multiple Applications in the Hospital Setting Poster Presentation Number: 2032 Presenting Author: Dr. Mark Chan
MUNICH, Germany, Sept. 2 /PRNewswire/ -- Regado Biosciences, Inc.
CRi Announces New Maestro(TM) EX In Vivo Imaging System with Improved Performance and an Affordable Price
WOBURN, Mass., Aug. 26 /PRNewswire/ -- Cambridge Research &
Instrumentation, Inc. (CRi) announces the release of the Maestro(TM) EX In
Vivo Imaging System. The new system
incorporates CRi's state-of-the-art
FLEX technology and becomes the entry-level instrument of choice for in
First DuraHeart(TM) Left Ventricular Assist System Implanted in the U.S. Pivotal Trial
ANN ARBOR, Mich., Aug. 6 /PRNewswire/ -- Terumo Heart, Inc. announced
that the first U.S. implant of the DuraHeart(TM) Left Ventricular Assist
System (LVAS) took place on July 30 at the University of Michigan
Cardiovascular Center in Ann Arbor, Michigan. The surgery was performed by
Echo Therapeutics Announces Positive Results of a Clinical Study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
FRANKLIN, Mass., July 29 /PRNewswire-FirstCall/ -- Echo Therapeutics
(OTC Bulletin Board: ECTE) today announced positive results of a clinical
study of its Symphony(TM) Transdermal Continuous Glucose Monitoring (tCGM)
System in patients with Type 1 and Type 2 Diabetes. Echo's non-invasive
Cepheid GeneXpert(R) System and Xpert(TM) MRSA Selected for up to 11 Victoria, Australia Hospitals in Rollout of 'Start Clean' Strategy
State of Victoria, Australia 'Start Clean' Strategy Requires Public Reporting of HAIs in all 76 Public Hospitals by End of 2009
SUNNYVALE, Calif., July 28 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq:
CPHD) today announced that the State of Victoria has selected Cepheid's
Echo Therapeutics Announces Publication of Positive Clinical Data for its Symphony Transdermal Continuous Glucose Monitoring System in Journal of Diabetes Science and Technology
FRANKLIN, Mass., July 14 /PRNewswire-FirstCall/ -- Echo Therapeutics
(OTC Bulletin Board: ECTE) today announced publication of results from
three pilot clinical studies of its Symphony Transdermal Continuous Glucose
Monitoring (tCGM) System
in the Journal of Diabetes Science and Technology.
Echo Therapeutics Initiates Clinical Study of Its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
FRANKLIN, Mass., July 1 /PRNewswire-FirstCall/ -- Echo Therapeutics,
Inc. (OTC Bulletin Board: ECTE) announced today that it has initiated a
clinical study of its Symphony(TM) Transdermal Continuous Glucose
(tCGM System) in patients with Type 1 and Type 2
diabetes. The Compan...
Duke Licenses ALPHADAS(R), Logos Technologies EDC System to Accelerate its Early Phase Clinical Trials
LONDON, June 26 /PRNewswire/ -- Duke University Medical Center has
licensed ALPHADAS(R) Logos Technologies electronic data capture (EDC)
software to accelerate and streamline its early-phase clinical trials and
to enable physicians to follow patients more closely.
Researchers at Duke, which ...
Terumo Heart Obtains IRB Approval from the University of Michigan to Initiate DuraHeart(TM) Left Ventricular Assist System U.S. Pivotal Trial
ANN ARBOR, Mich., June 25 /PRNewswire/ -- Terumo Heart, Inc. announced
today approval from the Institutional Review Board (IRB) at the University
of Michigan to move forward with the DuraHeart(TM) Left Ventricular Assist
System (LVAS) U.S. Pivotal Trial for a Bridge-to-Transplant (BTT)
Studies of an Innovative Catheter Ablation System for Atrial Fibrillation Reveal Excellent Outcomes, Safety Profile and Fast Procedure Times
Presentations at Cardiostim World Congress Focus Attention on a New Ablation Technology
CARLSBAD, Calif., June 24 /PRNewswire/ -- Ablation Frontiers, Inc.
today announced that two studies reporting positive findings about its
novel atrial fibrillation catheter ablati...
Pressure BioSciences, Inc. Announces $850,000 NIH SBIR Phase II Award for the Development of a New PCT-dependent System for Improved Biomarker Discovery, Diagnostics, and Drug Discovery
SOUTH EASTON, Mass., June 24 /PRNewswire-FirstCall/ -- Pressure
BioSciences, Inc. (Nasdaq: PBIO ) ("PBI" and "the Company") today announced
that it has been awarded a Phase II Small Business Innovation Research
(SBIR) Grant (2R44GM079059-02) from the National Institutes of Health
(NIH). The G...
Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications
NeuRx DPS(TM) Allows Patients To Breathe Without Ventilator Clinical Trials Also Underway For ALS Patients
CLEVELAND, June 18 /PRNewswire/ -- Synapse Biomedical Inc.
(http://www.synapsebiomedical.com ) announced today it has received approval from
the U.S. Food and Drug Admi...